Late-breaking Results Show Efficacy for CCM in Patients With HFpEF
23 mai 2022 10h17 HE | Impulse Dynamics
MADRID and MARLTON, N.J., May 23, 2022 (GLOBE NEWSWIRE) -- Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure (HF), announced today a...
Impulse Dynamics Announces First Implants of Optimizer Smart Mini
10 mai 2022 13h50 HE | Impulse Dynamics
MARLTON, N.J., May 10, 2022 (GLOBE NEWSWIRE) -- Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure (HF), is announcing today the first...
Impulse Dynamics Launches Optimizer Smart Mini CCM Delivery System
29 avr. 2022 09h00 HE | Impulse Dynamics
MARLTON, N.J., April 29, 2022 (GLOBE NEWSWIRE) -- Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure (HF), is proud to announce today...
Impulse Dynamics Announces 7,000th Patient Treated With CCM Reinforcing Significant Clinical Experience
26 avr. 2022 09h00 HE | Impulse Dynamics
MARLTON, N.J., April 26, 2022 (GLOBE NEWSWIRE) -- Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure (HF), is proud to announce a...
Impulse Dynamics' Quality Management System Receives Certification Under European Union Medical Device Regulation
22 mars 2022 09h00 HE | Impulse Dynamics
MARLTON, N.J., March 22, 2022 (GLOBE NEWSWIRE) -- Impulse Dynamics, a company dedicated to innovative treatments for chronic heart failure, is pleased to announce that it has successfully completed...
Impulse Dynamics Announces First Patient Enrolled in AIM HIGHer — Implantable Device Trial to Treat Heart Failure in Higher EF Population
14 mars 2022 09h42 HE | Impulse Dynamics
MARLTON, N.J., March 14, 2022 (GLOBE NEWSWIRE) -- Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure (HF), today announced that the first...
54741_Image_jpeg.jpg
Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders
01 mars 2022 09h00 HE | Daxor Corporation
Oak Ridge, TN, March 01, 2022 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today issued a corporate update in a Letter to...
54741_Image_jpeg.jpg
Daxor Corporation Announces $1.35 Per Share NAV Increase and Files Annual Report for Fiscal 2021
01 mars 2022 08h00 HE | Daxor Corporation
Revenues of Operating Division Increase by 70.6% Oak Ridge, TN, March 01, 2022 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, filed...
IMPULSE DYNAMICS ANNOUNCES FIRST OPTIMIZER IMPLANT IN CHINA
01 nov. 2021 08h23 HE | Impulse Dynamics
MARLTON, N.J., Nov. 01, 2021 (GLOBE NEWSWIRE) -- Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure, today announced the first...
IMPULSE DYNAMICS RECEIVES FDA APPROVAL TO MODIFY LABELING FOR OPTIMIZER SMART MEDICAL DEVICES
26 oct. 2021 08h57 HE | Impulse Dynamics
MARLTON, N.J., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure (HF), today announced that the U.S....